TrialScientific reports2022

A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers.

Satoshi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.